🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The ARTEMIS-IPF study was conducted to determine if ambrisentan was effecti...
Status
Terminated
Location
University of Alabama at Birmingham Hospital
Start Date
2008-12
Trial ID
NCT00768300
Treatments Being Tested
Patients with COVID-19 frequently develop lower respiratory complications. ...
Status
Terminated
Location
General Hopital Zadar
Start Date
2021-02-08
Trial ID
NCT04771000
Treatments Being Tested
The purpose of this study is to investigate the effectiveness of a drug cal...
Status
Completed
Location
Nilanjana Bose, Md
Start Date
2010-02
Trial ID
NCT01072669
Treatments Being Tested
Trial Design Patients with borderline PAH indicated by borderline mPAP valu...
Status
Completed
Location
Thoraxclinic at the University of Heidelberg
Start Date
2014-07-01
Trial ID
NCT02290613
Treatments Being Tested
It is hypothesised that ambrisentan may provide benefit to subjects with in...
Status
Terminated
Location
GSK Investigational Site
Start Date
2013-09
Trial ID
NCT01884675
Treatments Being Tested
This is an investigator-initiated, multicenter, randomized, double-blind, p...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05-15
Trial ID
NCT06987097
Treatments Being Tested
An Investigator initiated trial (IIT) using a prospective, randomized, doub...
Status
Unknown
Location
Nanjing First Hospital
Start Date
2022-09-05
Trial ID
NCT04972656
Treatments Being Tested
Pulmonary arterial hypertension (PAH) is a rare, progressive disease associ...
Status
Recruiting
Location
Hôpital Bicêtre -Service de pneumologie et soins intensifs respiratoires
Start Date
2026-04-28
Trial ID
NCT07245680
Treatments Being Tested
The purpose of this study is to find out if spironolactone added to ambrise...
Status
Terminated
Location
Brigham & Women's Hospital
Start Date
2015-09
Trial ID
NCT02253394
Treatments Being Tested
The objective of this study is to identify insulin-specific cerebral blood ...
Status
Completed
Location
University of Wisconsin, Madison
Start Date
2017-01-31
Trial ID
NCT02936687